Hjem
Nils Erik Gilhuss bilde

Nils Erik Gilhus

Vit. assistent, Professor
  • E-postNils.Gilhus@uib.no
  • Telefon+47 55 97 50 74+47 55 97 50 44
  • Besøksadresse
    Gamle Hovedbygg, Haukeland Universitetssjukehus
    5021 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2014). EFNS/ENS Guidelines for the treatment of ocular myasthenia. European Journal of Neurology. 687-693.
  • Vis forfatter(e) (2013). The Norwegian Brain Council ('Hjerneradet') united efforts are necessary! Acta Neurologica Scandinavica. 1-4.
  • Vis forfatter(e) (2013). Psychiatric comorbidity and social aspects in pregnant women with epilepsy - The Norwegian Mother and Child Cohort Study. Epilepsy & Behavior. 379-385.
  • Vis forfatter(e) (2013). Exposure to antiepileptic drugs in utero and child development - a prospective population-based study. Epilepsia. 1462-1472.
  • Vis forfatter(e) (2013). Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding a prospective cohort study on children of women with epilepsy. JAMA Neurology. 1367-1374.
  • Vis forfatter(e) (2011). Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Research. 53-60.
  • Vis forfatter(e) (2011). Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. Muscle and Nerve. 574-577.
  • Vis forfatter(e) (2010). Publishing affects funding in neurology. European Journal of Neurology. 147-151.
  • Vis forfatter(e) (2010). Neurofilament ELISA validation. JIM - Journal of Immunological Methods. 23-31.
  • Vis forfatter(e) (2010). Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 1445-1450.
  • Vis forfatter(e) (2010). Mortality after traumatic spinal cord injury: 50 years of follow-up. Journal of Neurology, Neurosurgery and Psychiatry. 368-373.
  • Vis forfatter(e) (2010). Maternal epilepsy and adverse pregnancy outcomes. Expert Review of Obstetrics & Gynecology. 347-355.
  • Vis forfatter(e) (2010). MRI of the transverse and alar ligaments in rheumatoid arthritis: feasibility and relations to atlantoaxial subluxation and disease activity. Neuroradiology. 215-223.
  • Vis forfatter(e) (2010). Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 893-902.
  • Vis forfatter(e) (2010). Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 66-69.
  • Vis forfatter(e) (2010). Delivery outcome of women with epilepsy:a population-based cohort study. BJOG: An International Journal of Obstetrics and Gynaecology. 1537-1543.
  • Vis forfatter(e) (2010). Clinical aspects of myasthenia explained. Autoimmunity. 344-352.
  • Vis forfatter(e) (2010). Are MRI high-signal changes of alar and transverse ligaments in acute whiplash injury related to outcome? BMC Musculoskeletal Disorders.
  • Vis forfatter(e) (2010). Anti-heat shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barre syndrome. Journal of Neuroimmunology. 180-183.
  • Vis forfatter(e) (2010). A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway. Spinal Cord. 313-318.
  • Vis forfatter(e) (2009). Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology. 150-151.
  • Vis forfatter(e) (2009). Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 2130-2139.
  • Vis forfatter(e) (2009). Norwegian neurology: present status and future trends. Acta Neurologica Scandinavica. 5-7.
  • Vis forfatter(e) (2009). Myasthenia gravis in the elderly. Aging Health. 561-568.
  • Vis forfatter(e) (2009). MRI of the alar and transverse ligaments in whiplash-associated disorders (WAD) grades 1–2: high-signal changes by age, gender, event and time since trauma. Neuroradiology. 227-235.
  • Vis forfatter(e) (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 63-66.
  • Vis forfatter(e) (2009). Diagnostic coding accuracy for traumatic spinal cord injuries. Spinal Cord. 367-371.
  • Vis forfatter(e) (2009). Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG: An International Journal of Obstetrics and Gynaecology. 1736-1742.
  • Vis forfatter(e) (2009). Characteristics of generalised epileptiform activity. Clinical Neurophysiology. 3-10.
  • Vis forfatter(e) (2009). Autoimmune myasthenia gravis. Expert Review of Neurotherapeutics. 351-358.
  • Vis forfatter(e) (2008). Titin and ryanodine receptor antibodies and neurmuscular involvement in myasthenia gravis. Future Neurology. 87-92.
  • Vis forfatter(e) (2008). Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 96-99.
  • Vis forfatter(e) (2008). Report of the Task Force on pre-graduate education in Europe of the education committee of the European Federation of Neurological Societies Composition of the task force of the education committee on pre-graduate education. European Journal of Neurology. e103-e109.
  • Vis forfatter(e) (2008). Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. Journal of Neurology. 623-627.
  • Vis forfatter(e) (2008). Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis. Journal of Neuroimmunology. 28-32.
  • Vis forfatter(e) (2008). Norsk nevrologi markerer seg internasjonalt. Axonet. 18.
  • Vis forfatter(e) (2008). Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology. 74-79.
  • Vis forfatter(e) (2008). Myasthenia Gravis and the Heart. Advances in Clinical Neuroscience & Rehabilitation. 9-10.
  • Vis forfatter(e) (2008). Left ventricular long-axis function in myasthenia gravis. Journal of Neurology. 1777-1784.
  • Vis forfatter(e) (2008). A retrospective view on research in neuroscience in Norway. Acta Neurologica Scandinavica. 3-5.
  • Vis forfatter(e) (2007). Pregnancy, delivery and perinatal outcome in female survivors of polio. Journal of the Neurological Sciences. 27-32.
  • Vis forfatter(e) (2007). Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. European Journal of Neurology. 60-65.
  • Vis forfatter(e) (2007). Post-polio syndrome patients treated with intravenous immunoglobulin. A double blinded randomised controlled study. European Journal of Neurology. 60-65.
  • Vis forfatter(e) (2007). Polygenic disease associations in thymomatous myasthenia gravis. Archives of Neurology. 1729-1733.
  • Vis forfatter(e) (2007). Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. European Journal of Neurology. 617-620.
  • Vis forfatter(e) (2007). Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. European Journal of Neurology. 38-43.
  • Vis forfatter(e) (2007). Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. European Journal of Neurology. 1113-1117.
  • Vis forfatter(e) (2007). Focal epileptiform activity described by a large computerised EEG database. Clinical Neurophysiology. 1369-1376.
  • Vis forfatter(e) (2006). Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurologica Scandinavica. 19-23.
  • Vis forfatter(e) (2006). Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 51-54.
  • Vis forfatter(e) (2006). Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 51-54.
  • Vis forfatter(e) (2006). Myasthenia gravis: disease severity and prognosis. Acta Neurologica Scandinavica. 24-25.
  • Vis forfatter(e) (2006). Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. European Journal of Neurology. 913-922.
  • Vis forfatter(e) (2006). Guidelines for the treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 691-699.
  • Vis forfatter(e) (2006). Does myasthenia gravis provide protection against cancer? Acta Neurologica Scandinavica. 33-36.
  • Vis forfatter(e) (2006). Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. Journal of Neurology, Neurosurgery and Psychiatry. 203-207.
  • Vis forfatter(e) (2006). Bergen International symposium in neuroimmunology 2006. Introduction. Acta Neurologica Scandinavica, Supplementum. v-vi.
  • Vis forfatter(e) (2006). Artrogryposis multiplex congenita - a rare fetal condition caused by maternal myasthenia gravis. Acta Neurologica Scandinavica. 26-27.
  • Vis forfatter(e) (2005). The role of complement in myasthenia gravis; serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 191-194.
  • Vis forfatter(e) (2005). Seronegative myasthenia gravis; disease severity and prognosis. European Journal of Neurology. 413-418.
  • Vis forfatter(e) (2005). Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 1961-1963.
  • Vis forfatter(e) (2005). Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 459-462.
  • Vis forfatter(e) (2005). Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 459-462.
  • Vis forfatter(e) (2005). Fordypningsstillinger er en forskningsressurs. Tidsskrift for Den norske legeforening. 2224-2225.
  • Vis forfatter(e) (2005). Fordypningsstillinger er en forskningsressurs. Tidsskrift for Den norske legeforening. 2224-2225.
  • Vis forfatter(e) (2004). Tymektomi og muskelantistoffer ved myasthenia gravis. Tidsskrift for Den norske legeforening. 629-631.
  • Vis forfatter(e) (2004). MRI of the posterior tectorial and atlanto-occipital membranes in the late stage of whiplash injury. Neuroradiology. 167-168.
  • Vis forfatter(e) (2004). Lifestyle and late effects after poliomyelitis. A risk factor study of two populations. Acta Neurologica Scandinavica. 120-125.
  • Vis forfatter(e) (2004). Intravenøst immunoglobulin ved postpolio syndrom. Tidsskrift for Den norske legeforening. 2357-2358.
  • Vis forfatter(e) (2004). Guidelines by the European Federation of Neurological Societies (EFNS) subcommittee for continuing medical education (CME). European Journal of Neurology. 145-151.
  • Vis forfatter(e) (2004). Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. European Journal of Neurology. 577-582.
  • Vis forfatter(e) (2004). EEG background activity described by a large computerized database. Clinical Neurophysiology. 665-673.
  • Vis forfatter(e) (2004). Cytoxic Effects of Myasthenia Gravis Patient Sera on Primary Human Skeletal Muscle Cell Cultures. Immunology. 131-134.
  • Vis forfatter(e) (2004). Asymptomatic myasthenia gravis influences pregnancy and birth. European Journal of Neurology. 559-562.
  • Vis forfatter(e) (2003). Thymectomy in non-thymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European Neurology. 210-217.
  • Vis forfatter(e) (2003). Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 481-490.
  • Vis forfatter(e) (2003). Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 453-456.
  • Vis forfatter(e) (2003). Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle &Nerve. 81-89.
  • Vis forfatter(e) (2003). Research and specialty associations of the Medical Society. Tidsskrift for Den norske legeforening. 1370-1371.
  • Vis forfatter(e) (2003). Post polio syndrome and total health status in a prospective health study. European Journal of Neurology. 407-413.
  • Vis forfatter(e) (2003). Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 350-353.
  • Vis forfatter(e) (2003). Om helsetjenesten. Fordypningsstillinger for å fremme medisinsk forskning. Tidsskrift for Den norske legeforening. 3415-3416.
  • Vis forfatter(e) (2003). Myesthenia gravis: Consequenses for pregnancy, delivery, and the newborn. Neurology. 1362-1366.
  • Vis forfatter(e) (2003). Myasthenia gravis. Consequences for pregnancy, delivery, and the newborn. Neurology. 1362-1366.
  • Vis forfatter(e) (2003). Myasthenia gravis in individuals over forty. Annals of the New York Academy of Sciences. 424-431.
  • Vis forfatter(e) (2003). MRI of the tectorial and posterior atlanto-occipital membranes in the late stage of whiplash injury. Neuroradiology. 585-591.
  • Vis forfatter(e) (2003). MR analysis of the transverse ligament in the late stage of whiplash injury. Acta Radiologica. 637-644.
  • Vis forfatter(e) (2003). Long term outcome after poliomyelitis in different health and social conditions. Journal of Epidemiology and Community Health. 368-372.
  • Vis forfatter(e) (2003). GM1-antibodies in post-polio syndrome and previous paralytic polio. Journal of Neuroimmunology. 141-144.
  • Vis forfatter(e) (2003). Forskning og Legeforeningens spesialforeninger. Tidsskrift for Den norske legeforening. 1370-1371.
  • Vis forfatter(e) (2003). Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. European Journal of Neurology. 701-706.
  • Vis forfatter(e) (2003). Arvelige muskelsykdommer. Tidsskrift for Den norske legeforening. 2588-2592.
  • Vis forfatter(e) (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. Journal of Neuroimmunology. 82-89.
  • Vis forfatter(e) (2002). Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. European Journal of Neurology. 55-61.
  • Vis forfatter(e) (2002). The recognition, diagnosis and management of cerebral vasculitis: a European survey. European Journal of Neurology. 343-347.
  • Vis forfatter(e) (2002). Nevrololgiforskning i Norge. Axonet. 4-5.
  • Vis forfatter(e) (2002). Klasehodepine ("cluster Headache"). GlaxoSmithKline.
  • Vis forfatter(e) (2002). Forskning og forbindelser. Tidsskrift for Den norske legeforening. 1235.
  • Vis forfatter(e) (2002). Former poliomyelitis as a health and socioeconomic factor. A paired sibling study. Journal of Neurology. 404-409.
  • Vis forfatter(e) (2002). Education, occupation, and perception of health amongst previous polio patients compared to their siblings. European Journal of Neurology. 233-241.
  • Vis forfatter(e) (2001). Why research courses for medical students? Tidsskrift for Den norske legeforening. 1846-1847.
  • Vis forfatter(e) (2001). Task force on minimum standards for health care of people with multiple sclerosis. European Journal of Neurology. 215-220.
  • Vis forfatter(e) (2001). Neurology training abroad; OFTEN - a new european programme. Federation of Neurological Societies EFNS Newsletter. 2.
  • Vis forfatter(e) (2001). Hvorfor forskerlinje for medisinstudenter ? Tidsskrift for Den norske legeforening.
  • Vis forfatter(e) (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Archives of Neurology. 1596-1600.
  • Vis forfatter(e) (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 369-375.
  • Vis forfatter(e) (2000). EFNS Task Force Report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Journal of Neurology. 625-628.
  • Vis forfatter(e) (2000). Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. Journal of Neuroimmunology. 169-176.
  • Vis forfatter(e) (1998). Titin transcripts in thymoma. Annals of the New York Academy of Sciences. 422-426.
  • Vis forfatter(e) (1998). The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. European Journal of Neurology. 401-405.
  • Vis forfatter(e) (1998). Sårbutulisme ved heroinmisbruk. Tidsskrift for Den norske legeforening. 4363-4365.
  • Vis forfatter(e) (1998). Sårbotulisme ved heroinmisbruk. Tidsskrift for Den norske legeforening. 4357-4359.
  • Vis forfatter(e) (1998). Striational autoantibodies in myasthenia gravis patients recognizw I-band titin epitopes. Journal of Neuroimmunology. 98-108.
  • Vis forfatter(e) (1998). Polio; en akutt og epidemisk infeksjonssykdom. Polio. 6-11.
  • Vis forfatter(e) (1998). Nevrodagene 1990-97 - bred faglig mønstring for norske nevrologer. Tidsskrift for Den norske legeforening. 2953-2956.
  • Vis forfatter(e) (1998). Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. Annals of the New York Academy of Sciences. 530-533.
  • Vis forfatter(e) (1998). Myasthenia gravis sera containing anti-ryanodine receptor antibodies inhibit binding of (3H-) ryanodine to sarcoplasmic reticulum. Muscle and Nerve. 329-335.
  • Vis forfatter(e) (1998). Muscle striation antibodies in myasthenia gravis; diagnostic and functional significance. Annals of the New York Academy of Sciences. 505-515.
  • Vis forfatter(e) (1998). FcgRIIA and RIIIB polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 173-176.
  • Vis forfatter(e) (1998). Cell-mediated immune response against titin in myasthenia gravis; evidence for the involvment of Th1 and Th2 cells. Scandinavian Journal of Immunology. 76-82.
  • Vis forfatter(e) (1997). Trends in neurological rehabilitation: More resources required in Norway. WFNR update. 4-5.
  • Vis forfatter(e) (1997). Titin transcript in thymomas. Journal of Autoimmunity. 551-557.
  • Vis forfatter(e) (1997). Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. European Journal of Neurology. 131-137.
  • Vis forfatter(e) (1997). Standards in neurological rehabilitation; an EFNS Report. European Journal of Neurology. 325-331.
  • Vis forfatter(e) (1997). Postpoliosyndromet; en reell komplikasjon. Tidsskrift for Den norske legeforening. 510-513.
  • Vis forfatter(e) (1997). Poliomyelitis: long-time consequences for social life. Acta Neurologica Scandinavica. 353-358.
  • Vis forfatter(e) (1997). Nevrologers arbeidsoppgave er høyspesialisert legearbeid. Axonet. 4-5.
  • Vis forfatter(e) (1997). Nevrologer;en etterspurt ressurs. Axonet. 3-4.
  • Vis forfatter(e) (1997). Neurology in Norway. [abstract]. World Neurology. 5.
  • Vis forfatter(e) (1997). Neurology in Norway. World Neurology. S. 5.
  • Vis forfatter(e) (1997). Diagnostikk av thymom og thymusatrofi hos pasienter med myasthenia gravis. Tidsskrift for Den norske legeforening. 4212-4214.
  • Vis forfatter(e) (1997). Diagnostikk av thymom og thumusatrofi hos pasienter med myasthenia gravis. Tidsskrift for Den norske legeforening. 4212-4214.
  • Vis forfatter(e) (1997). Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 111-116.
  • Vis forfatter(e) (1997). Arbeidsoppgaver for nevrologer - og for Norsk Neurologisk Forening. Axonet. 3-5.
  • Vis forfatter(e) (1996). Neurologi - kan rekrutteringen dekke behovet? Tidsskrift for Den norske legeforening. 3354-3358.
  • Vis forfatter(e) (1993). IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. Journal of Autoimmunity. 507-515.
  • Vis forfatter(e) (1991). Cerebral luftemboli etter perkutan lungepunksjon. Tidsskrift for Den norske legeforening. 3173-3175.
Vitenskapelig foredrag
  • Vis forfatter(e) (2013). Doesmother’s epilepsy or its treatment affect the brain of the child?
  • Vis forfatter(e) (2013). Anxiety and depression before and after delivery in pregnant women with epilepsy - A prospective, population based study.
  • Vis forfatter(e) (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules.
  • Vis forfatter(e) (2002). Deliveries among women affected by myasthenia gravis in Norway 1967-1998.
  • Vis forfatter(e) (2001). Thymectomy and muscle autoantibodies in myasthenia gravis.
  • Vis forfatter(e) (2001). Long-time consequences of poliomylitis in Norway and Estonia.
  • Vis forfatter(e) (2001). Influence of previous polio on socioeconomic factors and general health evaluated by matched pair analysis.
  • Vis forfatter(e) (2001). Behandling av myasthenia gravis; kontrollerte undersøkelser og klinisk erfaring.
  • Vis forfatter(e) (2001). Autoimmunity against the ryanodine receptor in myasthenia gravis.
  • Vis forfatter(e) (2001). Autoimmunity against the ryanodine receptor in myasthenia gravis.
  • Vis forfatter(e) (1998). Thymus dysfunction and thymectomy in myasthenia gravis.
Vitenskapelig antologi/Konferanseserie
  • Vis forfatter(e) (2015). Novel Challenges in Myasthenia Gravis. Nova Science Publishers.
  • Vis forfatter(e) (2015). Handbook of Neurological Therapy. Oxford University Press.
  • Vis forfatter(e) (2012). European Handbook of Neurological Management, Volume 2. Wiley-Blackwell.
  • Vis forfatter(e) (2011). Screening for tumours in paraneoplastic syndromes. Wiley-Blackwell.
  • Vis forfatter(e) (2011). Intravenous immunoglobulin in the treatment of neurological diseases. Wiley-Blackwell.
  • Vis forfatter(e) (2011). European Handbook of Neurological Management. Volume 2. Wiley-Blackwell.
  • Vis forfatter(e) (2011). European Handbook of Neurological Management. Wiley-Blackwell.
  • Vis forfatter(e) (2006). European Handbook of Neurological Management. Blackwell Publishing.
Sammendrag/abstract
  • Vis forfatter(e) (2011). Revised EFNS guidelines for diagnosis and management of post-polio syndrome. Journal of Rehabilitation Medicine. 12.
  • Vis forfatter(e) (2011). PSYCHIATRIC DISEASE AND SOCIAL CHARACTERISTICS IN WOMEN WITH EPILEPSY. THE MoBa DATABASE. European Journal of Neurology. 182-182.
  • Vis forfatter(e) (2010). Traumatic spinal cord injury and concomitant brain injury: a 50-year cohort study. European Journal of Neurology. 66-66.
  • Vis forfatter(e) (2010). Myasthenia gravis (MG) in the elderly and MG with anti-ryanodine receptor (RyR) antibodies. European Journal of Neurology. 628-628.
  • Vis forfatter(e) (2009). Poliomyelitis: beyond the year 2000. Journal of the Neurological Sciences. S6-S6.
  • Vis forfatter(e) (2009). Myasthenia gravis requiring drug treatment in a national population cohort. European Journal of Neurology. S207.
  • Vis forfatter(e) (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. European Journal of Neurology. 49-49.
  • Vis forfatter(e) (2009). Health and development in children born to mothers with epilepsy. European Journal of Neurology. 46-46.
  • Vis forfatter(e) (2009). Geographical distribution of the Norwegian seropositive myasthenia gravis population. European Journal of Neurology. 221-221.
  • Vis forfatter(e) (2008). The risk of extrathymic malignancies in thymoma patients with and without myasthenia gravis. European Journal of Neurology. 150-150.
  • Vis forfatter(e) (2008). Scientific activity within the European federation of neurological societies by Norwegian and British neurologists. Journal of Neurology, Neurosurgery and Psychiatry. 346-346.
  • Vis forfatter(e) (2008). Respiratory and cardiovascular dysfunctions are the main causes of death after traumatic spinal cord injury. European Journal of Neurology. 18-18.
  • Vis forfatter(e) (2008). Cytotoxic effects of myasthenia gravis sera on cardiomyocytes in vitro. Journal of Neuroimmunology. 154-155.
  • Vis forfatter(e) (2008). Acetylcholine receptor antibodies in Norwegian myasthenia gravis patients. European Journal of Neurology. 154-154.
  • Vis forfatter(e) (2007). Smoking habits in pregnant MS women. European Journal of Neurology. 278-278.
  • Vis forfatter(e) (2007). Pregnancy, delivery and outcome for the child in maternal epilepsy. European Journal of Neurology. 27-28.
  • Vis forfatter(e) (2007). Perinatal factors and later development of multiple sclerosis. Multiple Sclerosis. S91-S92.
  • Vis forfatter(e) (2007). Focal epileptiform activity described by a large computerised EEG database. European Journal of Neurology. 224-224.
  • Vis forfatter(e) (2006). Pregnancy, delivery and birth outcome in mothers prior to debut of multiple sclerosis. European Journal of Neurology. 28-29.
  • Vis forfatter(e) (2006). Pregnancy, birth and perinatal outcome in women with former polio - Health aspects of polio sequel in fertile age. European Journal of Neurology. 30-30.
  • Vis forfatter(e) (2006). Myasthenia gravis in pregnancy - Identifying risk factors, optimizing care. European Journal of Neurology. 24-24.
  • Vis forfatter(e) (2006). Does myasthenia gravis provide protection against cancer? European Journal of Neurology. 24-24.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2021). Physical training and exercise in myasthenia gravis. Neuromuscular Disorders. 169-173.
  • Vis forfatter(e) (2021). Advances and challenges in the treatment of myasthenia gravis. Therapeutic Advances in Neurological Disorders (TAND). 1-12.
  • Vis forfatter(e) (2020). Myasthenia gravis can have consequences for pregnancy and the developing child. Frontiers in Neurology. 1-6.
  • Vis forfatter(e) (2019). Myasthenia gravis - optimal treatment in severe disease. European Neurological Review. 81-85.
  • Vis forfatter(e) (2019). Myasthenia gravis. Nature Reviews Disease Primers. 1-19.
  • Vis forfatter(e) (2018). Developing treatment guidelines for myasthenia gravis. Annals of the New York Academy of Sciences. 95-101.
  • Vis forfatter(e) (2017). Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Current Opinion in Immunology. 9-13.
  • Vis forfatter(e) (2016). Myasthenia gravis - Autoantibody characteristics and their implications for therapy. Nature Reviews Neurology. 259-268.
  • Vis forfatter(e) (2016). Myasthenia gravis. New England Journal of Medicine. 2570-2581.
  • Vis forfatter(e) (2016). International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 419-425.
  • Vis forfatter(e) (2015). Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurology. 1023-1036.
  • Vis forfatter(e) (2015). Myasthenia gravis and risks for comorbidity. European Journal of Neurology. 17-23.
  • Vis forfatter(e) (2015). Epilepsy and recommendations for breastfeeding. Seizure. 57-65.
  • Vis forfatter(e) (2015). Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: A review of frequency, risks and recommendations for treatment. Seizure. 39-45.
  • Vis forfatter(e) (2015). Complicating autoimmune diseases in myasthenia gravis: A review. Autoimmunity. 362-368.
  • Vis forfatter(e) (2012). Traumatic spinal cord injuries - incidence, mechanisms and course. Tidsskrift for Den norske legeforening. 831-837.
  • Vis forfatter(e) (2012). Serum levels of matrix metalloproteinases: Implications in clinical neurology. European Neurology. 121-128.
  • Vis forfatter(e) (2012). Pregnancy complications in patients with epilepsy. Current Opinion in Obstetrics and Gynecology. 78-83.
  • Vis forfatter(e) (2012). Myasthenia and the neuromuscular junction. Current Opinion in Neurology. 523-529.
  • Vis forfatter(e) (2012). Advances in the treatment of myasthenia gravis. Future Neurology. 701-708.
  • Vis forfatter(e) (2011). Treatment for postpolio syndrome. Cochrane Database of Systematic Reviews. 92 sider.
  • Vis forfatter(e) (2011). Heat-Shock Proteins in Clinical Neurology. European Neurology. 65-69.

Se fullstendig oversikt over publikasjoner i CRIStin.